December 2008 news about us

Articles that mention MVI

Winning the fight against malaria
December 30, 2008 – The latest results of malaria vaccine trials in Africa, published online in the New England Journal of Medicine (NEJM), have revealed it more than halves the number of serious bouts of the disease in small children. Initial trials in Mozambique found the vaccine decreased, by almost a third, the number of cases of malaria necessitating clinical care. In the new trials in Tanzania and Kenya, it reduced such cases by 53 percent in 5 - 17-month-old babies.
Africa Today (UK)

The Glaxo-Gates malaria vaccine
December 14, 2008 - Researchers have been trying for more than 70 years to develop a vaccine against the elusive malaria parasite without notable success. Two studies conducted in East Africa suggest that they are finally closing in on their goal. The Bill and Melinda Gates Foundation deserves huge credit for enabling this research to go forward when the drug manufacturer was unwilling, on its own, to take the financial risk to try to develop a vaccine.
The New York Times

A jab of hope
December 11, 2008 - For much of the 19th century, Bagamoyo was a dreadful place, at the heart of the east African slave trade. The very name of the Tanzanian port means “lay down your heart” in Swahili. But that tragic association may be supplanted by a happier one, thanks to an important new study done in the city that shows how to tackle a killer that has long outlasted Bagamoyo’s trade in human beings.
The Economist

Malaria vaccine is given a good shot as big-money donors boost research
December 9, 2008 - LONDON - The fight against malaria, one of the world's biggest killers, has just gotten a booster. An experimental vaccine has shown promise in two studies in African children, who account for the majority of the more than one million victims that malaria claims every year. Published online Monday in the New England Journal of Medicine, the studies affirm encouraging results from earlier trials of the vaccine, known only as "RTS,S".
Wall Street Journal

Hope rises on malaria vaccine
December 9, 2008 - A major breakthrough may have been recorded in the efforts to eradicate malaria in vulnerable regions of the world with the discovery of a vaccine capable of providing both infant and young children with significant protection against malaria.
This Day (Nigeria)

Hope for malaria vaccine within five years
December 9, 2008 - A vaccine against malaria, which kills more than one million people every year, could be available within five years after extensive trials have shown that it provides significant protection for infants and young children.
The Independent (UK)

Un futur vaccin antipaludéen destiné aux enfants
December 9, 2008 - Un vaccin préventif contre le paludisme assurant une bonne protection dès le plus jeune âge pourrait être disponible dans quelques années. Telle est la conclusion encourageante qui peut être tirée de la publication, lundi 8 décembre sur le site du New England Journal of Medicine, des résultats de trois études menées en Tanzanie et au Kenya à partir d'un vaccin expérimental mis au point par la firme GlaxoSmithKline (GSK).
Le Monde (France)

Veelbelovend vaccin tegen malaria ontwikkeld
December 9, 2008 - AMSTERDAM - Het Belgisch/Britse farmabedrijf GSK heeft een vaccin ontwikkeld tegen malaria dat jonge kinderen een grote mate van bescherming biedt, blijkt uit twee onderzoeken in Tanzania en Kenia. De onderzoeksresultaten zijn dinsdag gepubliceerd op de internetsite van The New England Journal of Medicine (NEJM).
De Volkskrant (Netherlands)

A vaccine that could help wipe out malaria
December 8, 2008 - The only good thing about most epidemics is that if you act fast you can snuff them out before a local brushfire becomes a global blaze. That's what happened in 2002, when the SARS outbreak was contained after claiming thousands - rather than millions - of lives worldwide. That's what failed to happen in 1918, when a rare avian flu made the jump to humans and killed 50 million poeple before it was brought to heel. Malaria has always been a far harder scourge to control.
TIME Magazine

Malaria vaccine may be available by 2012
December 8, 2008 - A vaccine against the parasitic disease malaria cut illnesses by more than half in field trials and could safely be given with other childhood innoculations, two studies have reported. The vaccine, which will begin a third and final phas of clinical trials early next year, could become the first to protect chidlren from malaria, which kills 1 million poeple worldwide every year.
Los Angeles Times

Gates, PATH work closer to effective malaria vaccine
December 8, 2008 - An improved version of an old experimental malaria vaccine that had been improved largely due to new funding by the Gates Foundation has been shown in two new studies in Kenya and Tanzania to be effective enough to justify moving it to the final stages of scientific testing.
Seattle Post-Intelligencer

World close to first malaria vaccine
December 8, 2008 - The world may soon have its first vaccine against malaria. Results of Phase II human trials of the world's most clinically advanced malaria vaccine candidate - called RTS,S/AS - was found to offer protection to both babies and young children in Africa, reports the New England Journal of Medicine.
Hindustan Times

Glaxo malaria vaccine protects babies, children
December 8, 2008 - An experimental malaria vaccine is the most promising yet, protecting up to 65 percent of infants from infection in two studies in Africa, researchers reported on Monday. Separate tests in Kenya and Tanzania showed GlaxoSmithKline's vaccine called RTS,S could protect babies and toddlers from infection with malaria and could prevent disease even in those already infected.
Reuters

Nigeria: fresh plot against malaria scourge in Lagos
December 8, 2008 - Malaria is a disease that nations of the world spend huge sums of money to control. It affects mostly children and women. In spite of innovations by developed countries to fight the disease, millions of people had lost their lives to it. Although malaria has been almost totally eradicated from the developed world, it remains a major disease in the Third World countries, including Nigeria.
Daily Independent (Nigeria)

Malaria vaccine cuts infection rates by "up to 65 percent"
December 8, 2008 - An experimental malaria vaccine was able to reduce the rate of infection and disease in children by 53 to 65 percent in two clinical trials conducted in Africa, according to studies released Monday. Researchers have been trying to develop a vaccine for the deadly, mosquito-borne illness which kills nearly a million people a year and sickens 250 million others for more than 70 years.
Agence France Presse

Malaria vaccine halves infections in trials
December 8, 2008 - The world's first vaccine against malaria is now closer to becoming a reality, thanks to promising results from two trials in Africa. In the trials, children receiving the RTS,S vaccine more than halved their chances of contracting malaria compared with non-recipients. "We're all very excited about it," says Philip Bejon of the University of Oxford, UK, lead researcher in one of the two trials.
New Scientist (UK)

Researchers announce promising malaria vaccine
December 8, 2008 - Researchers have announced that most promising experimental vaccine to date to protect infants and young children against malaria. Investigators said the candidate vaccine will begin its final regulatory hurdle next year.
Voice of America

Malaria vaccine shows promising results
December 8, 2008 - An experimental malaria vaccine for babies reduced the chances of developing the mosquito-borne illness by more than half, scientists are reporting today. The results, from two trials conducted in Kenya and Tanzania, are the most promising yet in the quest to develop effective immunization against the life-threatening parasite.
Scientific American - 60 Second Science Blog

Malaria vaccine candidate advancing in Africa, study
December 8, 2008 - Results published online today in the New England Journal of Medicine revealed the world's most clinically advanced malaria vaccine candidate provides both infants and young children with significant protection against malaria.
Africa Science News Service